Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Western University: London, CA

Employment
Source: Self-asserted source
Cory Yamashita

Education and qualifications (1)

Western University: ON, ON, CA

Associate Professor (Medicine)
Qualification
Source: Self-asserted source
Cory Yamashita

Works (24)

Airway Mucus in Older People Without Chronic Respiratory Illness.

Chest
2024-05-28 | Journal article
DOI: 10.1016/j.chest.2024.04.023
PMID: 38815621
Contributors: Harkiran K Kooner; Hana Serajeddini; Eddy RL; Yamashita C; Sarah Svenningsen; Parraga G
Source: Self-asserted source
Cory Yamashita

Pulmonary Vascular Differences in Eosinophilic Asthma after 2.5 Years of Anti-IL-5Rα Treatment.

American journal of respiratory and critical care medicine
2023-11-01 | Journal article
DOI: 10.1164/rccm.202305-0849le
PMID: 37603773
Contributors: McIntosh MJ; Matheson AM; Kooner HK; Eddy RL; Serajeddini H; Yamashita C; Grace Parraga
Source: Self-asserted source
Cory Yamashita

<sup>129</sup>Xe MRI Ventilation Defects in Asthma: What is the Upper Limit of Normal and Minimal Clinically Important Difference?

Academic radiology
2023-04-08 | Journal article
DOI: 10.1016/j.acra.2023.03.010
PMID: 37032278
Contributors: McIntosh MJ; Alexander Biancaniello; Kooner HK; Bhalla A; Serajeddini H; Yamashita C; Grace Parraga; Eddy RL
Source: Self-asserted source
Cory Yamashita

CT Mucus Score and <sup>129</sup>Xe MRI Ventilation Defects After 2.5 Years' Anti-IL-5Rα in Eosinophilic Asthma.

Chest
2023-02-11 | Journal article
DOI: 10.1016/j.chest.2023.02.009
PMID: 36781102
Contributors: McIntosh MJ; Harkiran K Kooner; Eddy RL; Wilson A; Hana Serajeddini; Bhalla A; Christopher Licskai; Mackenzie CA; Yamashita C; Grace Parraga
Source: Self-asserted source
Cory Yamashita

Asthma Control, Airway Mucus, and <sup>129</sup>Xe MRI Ventilation After a Single Benralizumab Dose.

Chest
2022-03-10 | Journal article
DOI: 10.1016/j.chest.2022.03.003
PMID: 35283104
Contributors: Marrissa McIntosh; Harkiran K Kooner; Eddy RL; Jeimy S; Licskai C; Mackenzie CA; Svenningsen S; Nair P; Yamashita C; Grace Parraga
Source: Self-asserted source
Cory Yamashita

The impact of maternal protein restriction during perinatal life on the response to a septic insult in adult rats.

Journal of developmental origins of health and disease
2020-12-23 | Journal article
DOI: 10.1017/s2040174420001269
PMID: 33353580
Contributors: Reza Khazaee; Anastasiya Vinokurtseva; McCaig LA; Yamashita C; Daniel Hardy; Arany E; Ruud Veldhuizen
Source: Self-asserted source
Cory Yamashita

Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo.

Lung
2020-10-26 | Journal article
DOI: 10.1007/s00408-020-00399-2
PMID: 33106891
PMC: PMC7587541
Contributors: Brandon Baer; McCaig L; Yamashita C; Ruud Veldhuizen
Source: Self-asserted source
Cory Yamashita

COVID-19 and return-to-work recommendations for people with chronic respiratory diseases.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
2020-08-01 | Journal article
DOI: 10.1503/cmaj.76441
PMID: 32868276
PMC: PMC7458682
Contributors: Deschner M; Grace Parraga; Yamashita C
Source: Self-asserted source
Cory Yamashita

Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2.

Scientific reports
2020-06-10 | Journal article
DOI: 10.1038/s41598-020-66448-1
PMID: 32523049
PMC: PMC7287084
Contributors: Brandon Baer; Veldhuizen EJA; Natalia Molchanova; Shehrazade Jekhmane; Weingarth M; Håvard Jenssen; Jennifer Lin; Annelise Barron; Yamashita C; Veldhuizen R
Source: Self-asserted source
Cory Yamashita

Maternal protein restriction during perinatal life affects lung mechanics and the surfactant system during early postnatal life in female rats.

PloS one
2019-04-19 | Journal article
DOI: 10.1371/journal.pone.0215611
PMID: 31002676
PMC: PMC6474624
Source: Self-asserted source
Cory Yamashita

The wet bridge transfer system: a novel tool to assess exogenous surfactant as a vehicle for intrapulmonary drug delivery.

Discovery medicine
2018-11-01 | Journal article
PMID: 30695680
Source: Self-asserted source
Cory Yamashita

Killing of Pseudomonas aeruginosa by Chicken Cathelicidin-2 Is Immunogenically Silent, Preventing Lung Inflammation In Vivo.

Infection and immunity
2017-11-17 | Journal article
DOI: 10.1128/IAI.00546-17
PMID: 28947647
PMC: PMC5695126
Source: Self-asserted source
Cory Yamashita

The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens.

Scientific reports
2017-11-14 | Journal article
DOI: 10.1038/s41598-017-15558-4
PMID: 29138462
PMC: PMC5686076
Source: Self-asserted source
Cory Yamashita

Impact of ventilation-induced lung injury on the structure and function of lamellar bodies.

American journal of physiology. Lung cellular and molecular physiology
2017-05-25 | Journal article
DOI: 10.1152/ajplung.00055.2017
PMID: 28546153
Source: Self-asserted source
Cory Yamashita

Lung remodeling associated with recovery from acute lung injury.

Cell and tissue research
2016-10-29 | Journal article
DOI: 10.1007/s00441-016-2521-8
PMID: 27796509
Source: Self-asserted source
Cory Yamashita

Lack of matrix metalloproteinase 3 in mouse models of lung injury ameliorates the pulmonary inflammatory response in female but not in male mice.

Experimental lung research
2016-09-27 | Journal article
DOI: 10.1080/01902148.2016.1231243
PMID: 27676418
Source: Self-asserted source
Cory Yamashita

The effect of diet-induced serum hypercholesterolemia on the surfactant system and the development of lung injury.

Biochemistry and biophysics reports
2016-06-08 | Journal article
DOI: 10.1016/j.bbrep.2016.06.009
PMID: 28758151
PMC: PMC5527759
Source: Self-asserted source
Cory Yamashita

The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.

Canadian journal of physiology and pharmacology
2016-01-19 | Journal article
DOI: 10.1139/cjpp-2015-0377
PMID: 27096327
PMC: PMC5522962
Source: Self-asserted source
Cory Yamashita

Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia.

Antimicrobial agents and chemotherapy
2015-03-09 | Journal article
DOI: 10.1128/AAC.04937-14
PMID: 25753641
PMC: PMC4432191
Source: Self-asserted source
Cory Yamashita

Cholesterol-mediated surfactant dysfunction is mitigated by surfactant protein A.

Biochimica et biophysica acta
2014-12-16 | Journal article
DOI: 10.1016/j.bbamem.2014.12.009
PMID: 25522687
Source: Self-asserted source
Cory Yamashita

Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS.

Chest
2014-10-01 | Journal article
DOI: 10.1378/chest.14-0397
PMID: 25287998
PMC: PMC4188143
Source: Self-asserted source
Cory Yamashita

Apolipoprotein E-deficient mice are susceptible to the development of acute lung injury.

Respiration; international review of thoracic diseases
2014-03-22 | Journal article
DOI: 10.1159/000358438
PMID: 24662316
PMC: PMC4659709
Source: Self-asserted source
Cory Yamashita

Lung-derived mediators induce cytokine production in downstream organs via an NF-κB-dependent mechanism.

Mediators of inflammation
2013-03-27 | Journal article
DOI: 10.1155/2013/586895
PMID: 23606793
PMC: PMC3625542
Source: Self-asserted source
Cory Yamashita

The effect of tidal volume on systemic inflammation in Acid-induced lung injury.

Respiration; international review of thoracic diseases
2011-02-09 | Journal article
DOI: 10.1159/000323609
PMID: 21311175
Source: Self-asserted source
Cory Yamashita
How many people are using ORCID?